Sanjoinine A isolated from Zizyphi Spinosi Semen augments pentobarbital-induced sleeping behaviors through the modification of GABA-ergic systems

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 9, 2007, Pages 1748-1753

  Ma, Yuan ^a   Han, Huishan ^a   Eun, Jae Soon ^b   Kim, Hyung Chun ^c   Hong, Jin Tae ^a   Oh, Ki Wan ^a  

^a Chungbuk National University   (South Korea)

^b Woosuk University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

aminobutyric acid (GABA) receptor subunit; Cl influx; Pentobarbital; Sanjoinine A; Sleep; Zizyphi Spinosi Semen (ZSS)

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA; 4 AMINOBUTYRIC ACID A RECEPTOR BETA; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ALKALOID; CHLORIDE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; MUSCIMOL; PENTOBARBITAL; RECEPTOR SUBUNIT; SANJOININE A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASIA; CEREBELLUM; CHLORIDE TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; DRUG POTENTIATION; GABAERGIC SYSTEM; GRANULE CELL; HYPNOSIS; LATENT PERIOD; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; RAT; SLEEP; SLEEP TIME; ZIZYPHI SPINOSI SEMEN;

ANIMALS; CEREBELLUM; CHLORIDES; DRUG INTERACTIONS; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HYPNOTICS AND SEDATIVES; ISOENZYMES; MALE; MICE; MICE, INBRED ICR; MUSCIMOL; PENTOBARBITAL; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SLEEP; ZIZIPHUS;

EID: 34548635512     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1748     Document Type: Article

References (39)

1. Doghramji P. P., J. Clin. Psychiatry, 67, 5-8 (2006).
2. Zhao J., Li S. P., Yang F. Q., Li P., Wang Y. T., J. Chromatogr. A, 1108, 188-194 (2006).
3. Han Y. N., Hwang K. H., Han B. H., Arch. Pharm. Res., 28, 159-163 (2005).
4. Park J. H., Lee H. J., Koh S. B., Ban J. Y., Seong Y. H., J. Ethnopharmacol., 95, 39-45 (2004).
5. Heo H. J., Park Y. J., Suh Y. M., Choi S. J., Kim M. J., Cho H. Y., Chang Y. J., Hong B., Kim H. K., Kim E., Kim C. J., Kim B. G., Shin D. H., Biosci. Biotechnol. Biochem., 67, 1284-1291 (2003).
6. Matsuda H., Murakami T., Ikebata A., Yamahara J., Yoshikawa M., Chem. Pharm. Bull., 47, 1744-1748 (1999).
7. Yoshikawa M., Murakami T., Ikebata A., Wakao S., Murakami N., Matsuda H., Yamahara J., Chem. Pharm. Bull., 45, 1186-1192 (1997).
8. Adzu B., Amos S., Amizan M. B., Gamaniel K., Acta Trop., 87, 245-250 (2003).
9. Le C. G., Thepenier P., Richard B., Petermann C., Ghedira K., Zeches H. M., Lotusine G., Fitoterapia, 73, 63-68 (2002).
10. Suksamrarn S., Panseeta P., Kunchanawatta S., Distaporn T., Ruktasing S., Suksamrarn A., Chem. Pharm. Bull., 54, 535-537 (2006).
11. Lee S. M., Park J. G., Lee Y. H., Lee C. G., Min B. S., Kim J. H., Lee H. K., Biol. Pharm. Bull., 27, 1883-1886 (2004).
12. Su B. N., Cuendet M., Farnsworth N. R., Fong H. H., Pezzuto J. M., Kinghorn A. D., Planta Med., 68, 1125-1128 (2002).
13. Shou C. H., Wang J., Zheng X. X., Guo D. W., Acta Pharmacol. Sin., 22, 986-990 (2001).
14. Shou C., Feng Z., Wang J., Zheng X., Planta Med., 68, 799-803 (2002).
15. Zhang M., Ning G., Shou C., Lu Y., Hong D., Zheng X., Planta Med., 69, 692-695 (2003).
16. Adzu B., Amos S., Dzarma S., Wambebe C., Gamaniel K., J. Ethnopharmacol., 79, 13-16 (2002).
17. Morishita S., Mishima Y., Hirai Y., Saito T., Shoji M., Gen. Pharmacol., 18, 637-641 (1987).
18. Han B. H., Park M. H., Han Y. N., Yakhak Hoeji., 37, 143-148 (1993).
19. Han B. H., Park M. H., Park J. H., Pure Appl. Chem., 61, 443-448 (1989).
20. Wolfman C., Viola H., Marder M., Wasowski C., Ardenghi P., Izquierdo I., Eur. J. Pharmacol., 318, 23-30 (1996).
21. Darias V., Abdala S., Martin H. D., Tello M. L., Vega S., Pharmazie, 53, 477-481 (1998).
22. Houston C. M., Smart T. G., Eur. J. Neurosci., 24, 2504-2514 (2006).
23. West M. R., Molloy C. R., Anal. Biochem., 241, 51-58 (1996).
24. Liao J. F., Huang S. Y., Jan Y. M., Yu L. L., Chen C. F., J. Ethnopharmacol., 61, 185-193 (1998).
25. Olsen R. W., J. Neurochem., 37, 1-13 (1981).
26. Ticku M. K., Maksay G., Life Sci., 33, 2363-2375 (1984).
27. Chung K. F., Lee C. K., General Hospital Psychiatry, 24, 430-435 (2002).
28. Macdonald R. L., Olsen R. W., Annu. Rev. Neurosci., 17, 569-602 (1994).
29. Aprison M. H., Galvez R. E., Robertson D. H., Lipkowitz K. B., J. Neurosci. Res., 43, 372-381 (1996).
30. Waldvogel H. J., Baer K., Allen K. L., Rees M. I., Faull R. L., J. Comp. Neurol., 502, 1012-1029 (2007).
31. Wang G. H., Jiang Z. L., Fan X. J., Zhang L., Li X., Ke K. F., Neuropharmacology, 52, 1199-1209 (2007).
32. Ebert B., Thompson S. A., Saounatsou K., McKernan R., Krogsgaard L. P., Wafford K. A., Mol. Pharmacol., 52, 1150-1156 (1997).
33. Boehm S. L., Ponomarev I., Jennings A. W., Whiting P. J., Rosahl T. W., Garrett E. M., Blednov Y. A., Harris R. A., Biochem. Pharmacol., 68, 1581-1602 (2004).
34. Doghramji P. P., J. Clin. Psychiatry, 67, 5-8 (2006)
35. Chebib M., Johnston G., J. Med. Chem., 43, 1427-1447 (2000).
36. Johnston G., J. Proc. Roy. Soc., 135, 57-71 (2003).
37. Johnston G., Pharmacol. Therap., 69, 173-198 (1996).
38. Christopoulos A., Nature Rev. Drug Disc, 1, 198-210 (2002).
39. Zhang Z. J., Life Sci., 75, 1659-1699 (2004).